Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5. 2015

Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 Penn Street, Baltimore, MD 21201, United States.

Positive allosteric modulators (PAMs) binding to the transmembrane (TM) domain of metabotropic glutamate receptor 5 (mGluR5) are promising therapeutic agents for psychiatric disorders and traumatic brain injury (TBI). Novel PAMs based on a trans-2-phenylcyclopropane amide scaffold have been designed and synthesized. Facilitating ligand design and allowing estimation of binding affinities to the mGluR5 TM domain was the novel computational strategy, site identification by ligand competitive saturation (SILCS). The potential protective activity of the new compounds was evaluated using nitric oxide (NO) production in BV2 microglial cell cultures treated with lipopolysaccharide (LPS), and the toxicity of the new compounds tested using a cell viability assay. One of the new compounds, 3a, indicated promising activity with potency of 30 μM, which is 4.5-fold more potent than its lead compound 3,3'-difluorobenzaldazine (DFB), and showed no detectable toxicity with concentrations as high as 1000 μM. Thus this compound represents a new lead for possible development as treatment for TBI and related neurodegenerative disorders.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008971 Moles Any of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin. Mole
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D064529 Receptor, Metabotropic Glutamate 5 A type I G protein-coupled receptor mostly expressed post-synaptic pyramidal cells of the cortex and CENTRAL NERVOUS SYSTEM. Metabotropic Glutamate Receptor 5,Receptor 5, Metabotropic Glutamate,Metabotropic Glutamate Receptor 5a,Metabotropic Glutamate Receptor 5b,mGluR5 Protein,mGluR5a Protein,mGluR5b Protein,Protein, mGluR5,Protein, mGluR5a,Protein, mGluR5b

Related Publications

Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
January 2005, Current topics in medicinal chemistry,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
April 2015, Drug metabolism and disposition: the biological fate of chemicals,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
August 2011, ACS chemical neuroscience,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
January 2005, Current topics in medicinal chemistry,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
June 2013, ACS medicinal chemistry letters,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
September 2013, ACS medicinal chemistry letters,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
September 2003, Molecular pharmacology,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
March 2011, Bioorganic & medicinal chemistry letters,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
January 2014, CNS & neurological disorders drug targets,
Sirish K Lakkaraju, and Hannah Mbatia, and Marie Hanscom, and Zaorui Zhao, and Junfang Wu, and Bogdan Stoica, and Alexander D MacKerell, and Alan I Faden, and Fengtian Xue
November 2015, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!